• COVID-19
  • Biosimilars
  • Cataract Therapeutics
  • DME
  • Gene Therapy
  • Workplace
  • Ptosis
  • Optic Relief
  • Imaging
  • Geographic Atrophy
  • AMD
  • Presbyopia
  • Ocular Surface Disease
  • Practice Management
  • Pediatrics
  • Surgery
  • Therapeutics
  • Optometry
  • Retina
  • Cataract
  • Pharmacy
  • IOL
  • Dry Eye
  • Understanding Antibiotic Resistance
  • Refractive
  • Cornea
  • Glaucoma
  • OCT
  • Ocular Allergy
  • Clinical Diagnosis
  • Technology

Night-driving performance can be hindered after conventional LASIK

Article

Night-driving visual performance can decline after conventional LASIKin patients with higher levels of myopia preoperatively, reported StevenC. Schallhorn, MD, who spoke during the American Society of Cataract andRefractive Surgery (ASCRS) annual meeting.

Related Videos
Video 1 - "Challenging the Definition of Dry Eye- Interpreting Diagnostic Tests"
ASCRS 2024: ViaLase Updates on Nonincisional Glaucoma Treatment Targeting Trabecular Meshwork
Dr. Neda Nikpoor Shares Practical Techniques to Combat Unconscious Gender Bias and Promote Gender Equality in Ophthalmology
ASCRS 2024: George O. Waring, MD, shares early clinical performance of bilateral Odyssey implantation
ASCRS 2024: Deborah Gess Ristvedt, DO, discusses third-generation trabecular micro-bypass
Arjan Hura, MD, highlights the clinical and surgical updates at CIME 2024
Related Content
Study: Prevention of age-related truncation of γ-glutamylcysteine ligase catalytic subunit delays cataract formation

Study: Prevention of age-related truncation of γ-glutamylcysteine ligase catalytic subunit delays cataract formation

Article
Claris Bio's journey toward treating neurotrophic keratitis

Claris Bio's journey toward treating neurotrophic keratitis

Podcast
Aurion Biotech completes dosing of all subjects in Phase 1/2 CLARA trial

Aurion Biotech completes dosing of all subjects in Phase 1/2 CLARA trial

Article
Ehsan Sadri, MD, leads an ophthalmology innovation discussion with Jeffry Weinhuff of Visionary Ventures

(EyePod) From idea to impact: Navigating ophthalmic innovation

Podcast
Duke Biomedical Engineering chairman and OCT pioneer Joseph Izatt passes away

Duke Biomedical Engineering chairman and OCT pioneer Joseph Izatt passes away

Article
Coave Therapeutics showcases its Aligater platform for generating conjugated AAV vectors to deliver ocular gene therapy through suprachoroidal route

Coave Therapeutics showcases its Aligater platform for generating conjugated AAV vectors to deliver ocular gene therapy through suprachoroidal route

Article
© 2024 MJH Life Sciences

All rights reserved.